China, Singapore Scientists Map Genome Of ‘Bamboo Spine’ Disease
This article was originally published in PharmAsia News
China and Singapore researchers collaborated on a study they say has led to the first genome-mapping for risk of the spine disease, ankylosing spondylitis.
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.